Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 29:4:262.
doi: 10.3389/fmed.2017.00262. eCollection 2017.

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis

Vítor Teixeira  1 , Lai-Shan Tam  2
Affiliations
Review

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis

Vítor Teixeira et al. Front Med (Lausanne). .

Abstract

Introduction: The systemic inflammatory nature of systemic lupus erythematosus (SLE) is well patent not only in the diverse clinical manifestations of the disease but also in the increased risk of premature atherosclerosis and cardiovascular events (CVE), making SLE one of the most complex diseases to study and manage in clinical practice.

Aim: To travel from old aspects to modern insights on the physiopathology, new molecular biomarkers, imaging methods of atherosclerosis assessment, and the potential treatments of atherosclerosis in SLE.

Methods: We conducted a literature search using PubMed database and performed a critical review.

Conclusion/discussion: Several developments have taken place in the understanding of the relationship between SLE and premature atherosclerosis. Nevertheless, cardiovascular diseases are still the major cause of reduced life expectancy in SLE and the main cause of death. The lack of standardization methods for the imaging assessment of atherosclerosis in SLE and the multifactorial nature of the disease are well patriated in the difficulty of achieving consistent and reproducible results among studies that focus in cardiovascular risk assessment and prediction. A raising number of molecular biomarkers of atherosclerosis have been proposed, but the combination of several biomarkers and risk factors may better estimate cardiovascular disease risk. Moreover, the development of effective therapies to prevent progression of atherosclerosis and CVE shall address systemic inflammation.

Keywords: atherosclerosis; biomarkers; cardiovascular events; physiopathology; systemic lupus erythematosus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Main steps in the pathogenesis of atherosclerosis.
See this image and copyright information in PMC

References

    1. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull WJ, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb (1994) 14(5):840–56. 10.1161/01.ATV.14.5.840 - DOI - PubMed
    1. Libby P. Inflammation in atherosclerosis. Nature (2002) 420(6917):868–74. 10.1038/nature01323 - DOI - PubMed
    1. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 44(10):2331–7. 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I - DOI - PubMed
    1. Merrell M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis (1955) 1(1):12–32. 10.1016/0021-9681(55)90018-7 - DOI - PubMed
    1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients. Medicine (1999) 78(3):167–75. 10.1097/00005792-199905000-00003 - DOI - PubMed

LinkOut - more resources